Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents. 2004

Jing-Ping Liou, and Jang-Yang Chang, and Chun-Wei Chang, and Chi-Yen Chang, and Neeraj Mahindroo, and Fu-Ming Kuo, and Hsing-Pang Hsieh
Medicinal Synthetic Laboratory, Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taipei, Taiwan, Republic of China.

A new series of 3-aminobenzophenone compounds as potent inhibitors of tubulin polymerization was discovered based on the mimic of the aminocombretastatin molecular skeleton. Lead compounds 5 and 11, with alkoxy groups at the C-4 position of B-ring, were potent cytotoxic agents and inhibitors of tubulin polymerization through the binding to the colchicine-binding site of tubulin. The corresponding antitubulin activities of 5 and 11 were similar to or greater than combretastatin A-4 and AVE-8063. Replacement of the methoxy group with a chloro group in the B ring of aminobenzopheneones (3, 8, and 9) caused drastic decrease in cytotoxic and antitubulin activity except in compounds 4 and 10, which could result from a unique alignment between chloro and amino groups located at the para position to each other. SAR information revealed that introduction of an amino group at the C-3 position in B ring of benzophenones, in addition to a methoxy group at the C-4 position, plays an important role for maximal cytotoxicity.

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D003078 Colchicine A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE). Colchicine, (+-)-Isomer,Colchicine, (R)-Isomer
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000814 Aniline Compounds Compounds that include the aminobenzene structure. Phenylamine,Phenylamines,Anilines,Compounds, Aniline
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001577 Benzophenones Derivatives of benzophenone (with the structural formula phenyl-(C
D001704 Biopolymers Polymers synthesized by living organisms. They play a role in the formation of macromolecular structures and are synthesized via the covalent linkage of biological molecules, especially AMINO ACIDS; NUCLEOTIDES; and CARBOHYDRATES. Bioplastics,Bioplastic,Biopolymer
D013267 Stilbenes Organic compounds that contain 1,2-diphenylethylene as a functional group. Stilbene,Stilbene Derivative,Stilbene Derivatives,Stilbenoid,Stilbenoids,Derivative, Stilbene,Derivatives, Stilbene

Related Publications

Jing-Ping Liou, and Jang-Yang Chang, and Chun-Wei Chang, and Chi-Yen Chang, and Neeraj Mahindroo, and Fu-Ming Kuo, and Hsing-Pang Hsieh
February 2017, European journal of medicinal chemistry,
Jing-Ping Liou, and Jang-Yang Chang, and Chun-Wei Chang, and Chi-Yen Chang, and Neeraj Mahindroo, and Fu-Ming Kuo, and Hsing-Pang Hsieh
June 2008, Journal of medicinal chemistry,
Jing-Ping Liou, and Jang-Yang Chang, and Chun-Wei Chang, and Chi-Yen Chang, and Neeraj Mahindroo, and Fu-Ming Kuo, and Hsing-Pang Hsieh
February 2013, Journal of medicinal chemistry,
Jing-Ping Liou, and Jang-Yang Chang, and Chun-Wei Chang, and Chi-Yen Chang, and Neeraj Mahindroo, and Fu-Ming Kuo, and Hsing-Pang Hsieh
October 2006, Journal of medicinal chemistry,
Jing-Ping Liou, and Jang-Yang Chang, and Chun-Wei Chang, and Chi-Yen Chang, and Neeraj Mahindroo, and Fu-Ming Kuo, and Hsing-Pang Hsieh
March 2001, Journal of medicinal chemistry,
Jing-Ping Liou, and Jang-Yang Chang, and Chun-Wei Chang, and Chi-Yen Chang, and Neeraj Mahindroo, and Fu-Ming Kuo, and Hsing-Pang Hsieh
January 1991, Nucleic acids symposium series,
Jing-Ping Liou, and Jang-Yang Chang, and Chun-Wei Chang, and Chi-Yen Chang, and Neeraj Mahindroo, and Fu-Ming Kuo, and Hsing-Pang Hsieh
July 2007, Bioorganic & medicinal chemistry letters,
Jing-Ping Liou, and Jang-Yang Chang, and Chun-Wei Chang, and Chi-Yen Chang, and Neeraj Mahindroo, and Fu-Ming Kuo, and Hsing-Pang Hsieh
April 1993, Journal of medicinal chemistry,
Jing-Ping Liou, and Jang-Yang Chang, and Chun-Wei Chang, and Chi-Yen Chang, and Neeraj Mahindroo, and Fu-Ming Kuo, and Hsing-Pang Hsieh
January 2013, Molecules (Basel, Switzerland),
Jing-Ping Liou, and Jang-Yang Chang, and Chun-Wei Chang, and Chi-Yen Chang, and Neeraj Mahindroo, and Fu-Ming Kuo, and Hsing-Pang Hsieh
September 2009, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!